Indian Pharma Market Faces Q3FY25 Volume Decline Amid Pricing Gains ...Middle East

The Indian pharmaceutical market (IPM) has experienced negative volume growth in the third quarter of fiscal year 2025 after two successive quarters of modest gains, according to a report by Goldman Sachs. Despite this downturn, the market's performance has been buoyed by a robust 5.3% year-on-year rise in pricing and a 2.6% growth stemming from new product launches following recent patent expirations.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indian Pharma Market Faces Q3FY25 Volume Decline Amid Pricing Gains )

Also on site :

• Tragedy Strikes Amid Filipino Cultural Celebration in Vancouver
• Piyush Goyal Strengthens India-UK Trade Ties in London
• Sports Highlights: Resilient Athletes and Strategic Moves